TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
Fridsbo Pharma AB
Closing information (x1000 EUR)
| Closing information | 2023/12 | 2022/12 | 2021/12 |
| Turnover |
0
|
80
|
269 |
| Financial expenses |
0
|
0
|
0 |
| Earnings before taxes |
-60
|
3
|
200 |
| EBITDA |
-63
|
17
|
201 |
| Total assets |
180
|
302
|
326 |
| Current assets |
180
|
248
|
252 |
| Current liabilities |
11
|
72
|
79 |
| Equity capital |
167
|
214
|
230 |
| - share capital |
5
|
4
|
5 |
| Employees (average) |
2
|
1
|
1 |
Financial ratios
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Solvency |
92.8%
|
70.9%
|
70.6% |
| Turnover per employee |
0
|
80
|
269 |
| Profit as a percentage of turnover |
3.8%
|
74.3% | |
| Return on assets (ROA) |
-33.3%
|
1.0%
|
61.3% |
| Current ratio |
1636.4%
|
344.4%
|
319.0% |
| Return on equity (ROE) |
-35.9%
|
1.4%
|
87.0% |
| Change turnover |
-80
|
-167
|
198 |
| Change turnover % |
-100%
|
-68%
|
279% |
| Chg. No. of employees |
1
|
0
|
0 |
| Chg. No. of employees % |
100%
|
0%
|
0% |
Total value of public sale
| Fiscal year | 2023/12 | 2022/12 | 2021/12 |
| Total value of public sale |
0
|
0
|
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.